7-6009457-G-C

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_006303.4(AIMP2):​c.94G>C​(p.Gly32Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000412 in 1,457,528 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G32C) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000041 ( 0 hom. )

Consequence

AIMP2
NM_006303.4 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.187

Publications

0 publications found
Variant links:
Genes affected
AIMP2 (HGNC:20609): (aminoacyl tRNA synthetase complex interacting multifunctional protein 2) The protein encoded by this gene is part of the aminoacyl-tRNA synthetase complex, which contains nine different aminoacyl-tRNA synthetases and three non-enzymatic factors. The encoded protein is one of the non-enzymatic factors and is required for assembly and stability of the complex. [provided by RefSeq, May 2016]
AIMP2 Gene-Disease associations (from GenCC):
  • leukodystrophy, hypomyelinating, 17
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Illumina, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.07535988).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AIMP2NM_006303.4 linkc.94G>C p.Gly32Arg missense_variant Exon 1 of 4 ENST00000223029.8 NP_006294.2 Q13155-1A0A024QZY1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AIMP2ENST00000223029.8 linkc.94G>C p.Gly32Arg missense_variant Exon 1 of 4 1 NM_006303.4 ENSP00000223029.3 Q13155-1
AIMP2ENST00000395236.2 linkc.94G>C p.Gly32Arg missense_variant Exon 1 of 3 2 ENSP00000378658.2 Q13155-2
AIMP2ENST00000415999.1 linkn.94G>C non_coding_transcript_exon_variant Exon 1 of 3 3 ENSP00000392519.1 F8WCL2
AIMP2ENST00000400479.6 linkc.-251+79G>C intron_variant Intron 1 of 4 5 ENSP00000383327.2 A8MU58

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000412
AC:
6
AN:
1457528
Hom.:
0
Cov.:
32
AF XY:
0.00000276
AC XY:
2
AN XY:
725084
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33362
American (AMR)
AF:
0.00
AC:
0
AN:
44428
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26034
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39638
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86032
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52438
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4146
European-Non Finnish (NFE)
AF:
0.00000540
AC:
6
AN:
1111318
Other (OTH)
AF:
0.00
AC:
0
AN:
60132
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Feb 11, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.94G>C (p.G32R) alteration is located in exon 1 (coding exon 1) of the AIMP2 gene. This alteration results from a G to C substitution at nucleotide position 94, causing the glycine (G) at amino acid position 32 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
2.7
DANN
Benign
0.85
DEOGEN2
Benign
0.030
T;.
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.75
D
LIST_S2
Benign
0.63
T;T
M_CAP
Benign
0.0076
T
MetaRNN
Benign
0.075
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.74
N;N
PhyloP100
-0.19
PrimateAI
Benign
0.42
T
PROVEAN
Benign
-0.35
N;N
REVEL
Benign
0.056
Sift
Benign
0.22
T;T
Sift4G
Benign
0.14
T;T
Polyphen
0.0010
B;.
Vest4
0.22
MutPred
0.30
Gain of MoRF binding (P = 0.0288);Gain of MoRF binding (P = 0.0288);
MVP
0.061
MPC
0.035
ClinPred
0.11
T
GERP RS
-1.1
PromoterAI
-0.00060
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.10
gMVP
0.32
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200362634; hg19: chr7-6049088; API